Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (23)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hultén, K.
Right arrow Articles by Engstrand, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hultén, K.
Right arrow Articles by Engstrand, L.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (1996) 37, 483-489
© 1996 The British Society for Antimicrobial Chemotherapy


research-article

In-vitro activity of azithromycin against intracellular Helicobacter pylori

Kristina Hultén, Otto Cars, Eva Hjelm and Lars Engstrand

Department of Infectious Diseases and Clinical Microbiology, University Hospital Uppsala, Sweden

Received 20 January 1995; returned 5 April 1995; accepted 5 October 1995


We studied the effect in vitro of azithromycin on the clinical strain Helicobacter pylori H:72 growing intracellularly in monolayers of HEp-2 epithelial cells. After using gentamicin to eradicate extracellular bacteria, different concentrations of azithromycin were added to the infected cells and samples were taken after 0, 4, 8 and 24 h. Infected cells not exposed to antibiotic were included as controls. The MIC of azithromycin to the H. pylori was 0.25 mg/L and the MBC 0.5 mg/L in a broth dilution plate count method. A bactericidal effect was observed on intracellular H. pylori, with inhibition increasing with increasing azithromycin concentrations. However, extracellular concentrations of 200 x MBC were necessary to achieve intracellular killing . Our results show that azithromycin is active against intracellular H. pylori suggesting that it might be possible to exploit this activity when treating infections due to the organism.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Infect. Immun.Home page
T. Kwok, S. Backert, H. Schwarz, J. Berger, and T. F. Meyer
Specific Entry of Helicobacter pylori into Cultured Gastric Epithelial Cells via a Zipper-Like Mechanism
Infect. Immun., April 1, 2002; 70(4): 2108 - 2120.
[Abstract] [Full Text] [PDF]


Home page
Antimicrob. Agents Chemother.Home page
R. Piccolomini, G. Di Bonaventura, C. Picciani, F. Laterza, J. Vecchiet, and M. Neri
In Vitro Activity of Clarithromycin against Intracellular Helicobacter pylori
Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1568 - 1571.
[Abstract] [Full Text]


Home page
Infect. Immun.Home page
C. B. Forde, R. Parton, and J. G. Coote
Bioluminescence as a Reporter of Intracellular Survival of Bordetella bronchiseptica in Murine Phagocytes
Infect. Immun., July 1, 1998; 66(7): 3198 - 3207.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.